Bronson; Joanne J.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Bronson; Joanne J..The latest application filed is for "biaryl kinase inhibitors".
Company Profile
5.37.35
- Bronson; Joanne J. - Durham CT
- Bronson; Joanne J. - Dorham CT
- Bronson; Joanne J - Durham CT
- Bronson; Joanne J. - Madison CT
Patent Activity
| Patent | Date |
|---|---|
| Biaryl kinase inhibitors Grant 10,544,120 - Bronson , et al. Ja | 2020-01-28 |
| Aryl lactam kinase inhibitors Grant 10,253,027 - Hartz , et al. | 2019-04-09 |
| Biaryl kinase inhibitors Grant 10,246,469 - Bronson , et al. | 2019-04-02 |
| Biaryl Kinase Inhibitors App 20190040080 - BRONSON; Joanne J. ; et al. | 2019-02-07 |
| Fused pyridines as kinase inhibitors Grant 10,174,044 - Nara , et al. J | 2019-01-08 |
| Biaryl Kinase Inhibitors App 20180346440 - Bronson; Joanne J. ; et al. | 2018-12-06 |
| Heterocyclic kinase inhibitors Grant 10,035,777 - Dzierba , et al. July 31, 2 | 2018-07-31 |
| Fused Pyridines As Kinase Inhibitors App 20180141956 - Nara; Susheel Jethanand ; et al. | 2018-05-24 |
| Biaryl Kinase Inhibitors App 20180134704 - Luo; Guanglin ; et al. | 2018-05-17 |
| Quinoline-based kinase inhibitors Grant 9,932,320 - Hartz , et al. April 3, 2 | 2018-04-03 |
| Biaryl kinase inhibitors Grant 9,902,722 - Luo , et al. February 27, 2 | 2018-02-27 |
| Heterocyclic Kinase Inhibitors App 20170260145 - Dzierba; Carolyn Diane ; et al. | 2017-09-14 |
| Quinazoline-based Kinase Inhibitors App 20170239249 - HARTZ; Richard A. ; et al. | 2017-08-24 |
| Pyrrolotriazine kinase inhibitors Grant 9,737,542 - Dzierba , et al. August 22, 2 | 2017-08-22 |
| Triazolopyridine ether derivatives and their use in neurological and pyschiatric disorders Grant 9,738,642 - Marcin , et al. August 22, 2 | 2017-08-22 |
| Aryl amide-based kinase inhibitors Grant 9,708,337 - Vrudhula , et al. July 18, 2 | 2017-07-18 |
| Biaryl Kinase Inhibitors App 20170183340 - Luo; Guanglin ; et al. | 2017-06-29 |
| Oxazolidinones as modulators of mGluR5 Grant 9,688,669 - Degnan , et al. June 27, 2 | 2017-06-27 |
| Quinoline-Based Kinase Inhibitors App 20160332985 - Hartz; Richard A. ; et al. | 2016-11-17 |
| Aryl Lacta Kinase Inhibitors App 20160333006 - Vrudhula; Vivekananda M. ; et al. | 2016-11-17 |
| Pyrrolotriazine Kinase Inhibitors App 20160243125 - Dzierba; Carolyn Diane ; et al. | 2016-08-25 |
| Triazolopyridine Ether Derivatives And Their Use In Neurological And Pyschiatric Disorders App 20160237081 - Marcin; Lawrence R. ; et al. | 2016-08-18 |
| Oxazolidinones As Modulators Of Mglur5 App 20160237072 - Degnan; Andrew P. ; et al. | 2016-08-18 |
| Aryl Ether-base Kinase Inhibitors App 20160222021 - Vrudhula; Vivekananda M. ; et al. | 2016-08-04 |
| Imidazopyridazine Kinase Inhibitors Useful To Treating A Disease Or Disorder Mediated By Aak1, Such As Alzheimer's Disease, Bipolar Disorder, Pain, Schizophrenia App 20160199372 - HARTZ; Richard A. ; et al. | 2016-07-14 |
| Aryl Lactam Kinase Inhibitors App 20160152621 - Hartz; Richard A. ; et al. | 2016-06-02 |
| Aryl Amide-based Kinase Inhibitors App 20160016967 - Vrudhula; Vivekananda M. ; et al. | 2016-01-21 |
| Aryl ether-base kinase inhibitors Grant 8,969,564 - Vrudhula , et al. March 3, 2 | 2015-03-03 |
| Aryl lactam kinase inhibitors Grant 8,901,305 - Vrudhula , et al. December 2, 2 | 2014-12-02 |
| Aryl Ether-Base Kinase Inhibitors App 20140179725 - Vrudhula; Vivekananda M. ; et al. | 2014-06-26 |
| Aryl ether-base kinase inhibitors Grant 8,703,953 - Vrudhula , et al. April 22, 2 | 2014-04-22 |
| Aryl Lactam Kinase Inhibitors App 20140038999 - Vrudhula; Vivekananda M. ; et al. | 2014-02-06 |
| Aryl Ether-Base Kinase Inhibitors App 20130237555 - Vrudhula; Vivekananda M. ; et al. | 2013-09-12 |
| .alpha.-(N-sulfonamido)acetamide derivatives as .beta.-amyloid inhibitors Grant 8,513,253 - Parker , et al. August 20, 2 | 2013-08-20 |
| Modulators of G protein-coupled receptor 88 Grant 8,497,271 - Bi , et al. July 30, 2 | 2013-07-30 |
| Modulators of G protein-coupled receptor 88 Grant 8,426,414 - Bi , et al. April 23, 2 | 2013-04-23 |
| Pyrazinone modulator of corticotropin-releasing factor receptor activity Grant 8,372,847 - Hartz , et al. February 12, 2 | 2013-02-12 |
| Modulators of G protein-coupled receptor 88 Grant 8,304,577 - Dzierba , et al. November 6, 2 | 2012-11-06 |
| Substituted heterocyclic ethers and their use in CNS disorders Grant 8,071,778 - Parker , et al. December 6, 2 | 2011-12-06 |
| Modulators of G Protein-Coupled Receptor 88 App 20110251196 - Dzierba; Carolyn Diane ; et al. | 2011-10-13 |
| Modulators of G Protein-Coupled Receptor 88 App 20110251204 - Bi; Yingzhi ; et al. | 2011-10-13 |
| Modulators of G Protein-Coupled Receptor 88 App 20110245264 - Bi; Yingzhi ; et al. | 2011-10-06 |
| Substituted heterocyclic ethers and their use in CNS disorders Grant 8,026,257 - Degnan , et al. September 27, 2 | 2011-09-27 |
| Pyrazinone Modulator of Corticotropin-Releasing Factor Receptor Activity App 20110166160 - Hartz; Richard A. ; et al. | 2011-07-07 |
| Alpha-(N-Sulfonamido)Acetamide Derivatives as Beta-Amyloid Inhibitors App 20110105485 - Parker; Michael F. ; et al. | 2011-05-05 |
| (S)-4-(1-cyclopropyl-2-methoxyethyl)-6-(6-(difluoromethoxy)-2,5-dimethylpy- ridin-3-ylamino)-5-oxo-4,5-dihydropyrazine-2-carbonitrile: a pyrazinone modulator of corticotropin-releasing factor receptor activity Grant 7,932,256 - Hartz , et al. April 26, 2 | 2011-04-26 |
| .alpha.-(N-sulfonamido)acetamide derivatives as .beta.-amyloid inhibitors Grant 7,786,122 - Parker , et al. August 31, 2 | 2010-08-31 |
| Pyrazinone Modulator of Corticotropin-Releasing Factor Receptor Activity App 20100029684 - Hartz; Richard A. ; et al. | 2010-02-04 |
| Substituted heterocyclic ethers and their use in CNS disorders Grant 7,632,861 - Bronson , et al. December 15, 2 | 2009-12-15 |
| Substituted Heterocyclic Ethers and Their Use in CNS Disorders App 20090124613 - Bronson; Joanne J. ; et al. | 2009-05-14 |
| Substituted Heterocyclic Ethers and Their Use in CNS Disorders App 20090030040 - Parker; Michael F. ; et al. | 2009-01-29 |
| Substituted Heterocyclic Ethers and Their Use in CNS Disorders App 20090018163 - Schmitz; William D. ; et al. | 2009-01-15 |
| Substituted Heterocyclic Ethers and Their Use in CNS Disorders App 20090018132 - Degnan; Andrew P. ; et al. | 2009-01-15 |
| Alpha-(n-sulfonamido)acetamide Derivatives As Beta-amyloid Inhibitors App 20080085894 - Parker; Michael F. ; et al. | 2008-04-10 |
| Substituted Heterocyclic Ethers And Their Use In Cns Disorders App 20080027056 - Parker; Michael F. ; et al. | 2008-01-31 |
| .alpha.-(N-sulfonamido)acetamide derivatives as .beta.-amyloid inhibitors Grant 7,300,936 - Parker , et al. November 27, 2 | 2007-11-27 |
| Arylpyrrolidine derivatives as NK-1 /SSRI antagonists Grant 7,138,423 - Wu , et al. November 21, 2 | 2006-11-21 |
| O-derivatized nocathiacin derivatives Grant 7,022,667 - Hudyma , et al. April 4, 2 | 2006-04-04 |
| Arylpyrrolidine derivatives as NK-1 /SSRI antagonists App 20060020011 - Wu; Yong-Jin ; et al. | 2006-01-26 |
| Alpha-(N-sulfonamido)acetamide derivatives as beta-amyloid inhibitors App 20040127494 - Parker, Michael F. ; et al. | 2004-07-01 |
| O-derivatized nocathiacin derivatives App 20040018963 - Hudyma, Thomas W. ; et al. | 2004-01-29 |
| Water soluble thiazolyl peptide derivatives App 20020065219 - Naidu, B. Narasimhulu ; et al. | 2002-05-30 |
| Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives Grant 5,854,228 - Webb, II , et al. December 29, 1 | 1998-12-29 |
| Prodrugs of phosphonates Grant 5,792,756 - Starrett, Jr. , et al. August 11, 1 | 1998-08-11 |
| Prodrugs of phosphonates Grant 5,663,159 - Starrett, Jr. , et al. September 2, 1 | 1997-09-02 |
| Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives Grant 5,650,510 - Webb, II , et al. July 22, 1 | 1997-07-22 |
| Alicyclic phospholipase A.sub.2 inhibitors Grant 5,436,369 - Bronson , et al. July 25, 1 | 1995-07-25 |
| Use of chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents Grant 5,302,585 - Yu , et al. April 12, 1 | 1994-04-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 